Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New Plant-Based beverage aims to keep seniors healthier longer

NCT ID NCT07409480

Disease control Sponsor: University Rovira i Virgili Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a specially designed plant-based drink for adults aged 60 to 80. The drink contains vitamin D, zinc, and other nutrients meant to strengthen the immune system and reduce inflammation. Researchers will compare it to a plain plant-based drink over several weeks to see if it improves markers of health and nutrition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Functional plant-based beverage with vitamin D, zinc, FOS, and L-leucine
What this could lead to
If it works, this could point toward a simple dietary supplement that helps older adults maintain better immune function and reduce inflammation, supporting healthier aging.
What could go wrong
This is a small, early-stage trial with only 70 participants, so results may not apply broadly. The beverage is a dietary supplement, not a drug, so any benefits are likely modest and may not be clinically significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women ≥60 years old \<80 years old. * Written informed consent provided before the initial screening visit. Exclusion Criteria: * Hypoglycaemic treatment or type 1 and type 2 diabetes mellitus diagnosed. * Anaemia (haemoglobin ≤13 g/dL in men and ≤12 g/dL in women). * Intestinal malabsorption diseases, such as chron disease, colitis ulcerous, and irritable bowel syndrome. * Immune pathology or depressed immune system. * Use of antioxidants or nutritional supplements. * Known allergy or hypersensitivity to oat, coconut, or any formulation ingredient. * Renal diseases or history of hypercalcemia, sarcoidosis, or hyperparathyroidism. * History of inborn errors of metabolism affecting branched-chain amino acid metabolism. * Chronic alcoholism. * Current or past participation in a clinical trial or consumption of a research product in the 30 days before inclusion in the study. * Failure to follow the study guidelines.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Immune system are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction immune system disorder Inflammation inflammatory disease Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Immune system Inflammation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universitat Rovira i Virgili

    Reus, Tarragona, 43201, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.